Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.
Jiang W, He Y, He W, Wu G, Zhou X, Sheng Q, Zhong W, Lu Y, Ding Y, Lu Q, Ye F, Hua H. · 2020
Read Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy. by Jiang W, He Y, He W, Wu G, Zhou X, Sheng Q, Zhong W, Lu Y, Ding Y, Lu Q, Ye F, Hua H. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7902023.txt.
Description
Jiang and co-authors present a review of exhausted CD8+ T cells in tumours. T cells that face a tumour for a long time can wear down into a state called exhaustion. In that state they fail to control tumour growth. The review explains how the decline unfolds and what it means for therapy.
Exhaustion is not a single step. Cells pass from an early progenitor stage to a terminal stage. Each stage has distinct traits and markers. Checkpoint drugs work in part by expanding the progenitor pool. When that pool runs out, the drugs lose their effect. The authors argue that pairing checkpoint drugs with steps that shrink the tumour could help. So could steps that rebuild the progenitor pool. The review gives a clear frame for such combination plans.
Catalog record
| CREATOR | Jiang W, He Y, He W, Wu G, Zhou X, Sheng Q, Zhong W, Lu Y, Ding Y, Lu Q, Ye F, Hua H. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |